GL1X · GenesisL1 explorer

Research workbench

Structure of peroxisomal targeting signal 1 (PTS1) binding domain of trypanosoma brucei peroxin 5 (TBPEX5)COMPLEXED to T. brucei phosphoglucoisomerase (pgi) PTS1 peptide

Analyse Structure of peroxisomal targeting signal 1 (PTS1) binding domain of… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3CV0
Type
protein
Length
306 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome targeting signal 1 receptor PEX5; T. brucei pgi PTS1 peptide ac-fnelshl
UniProt
Q9U7C3, P13377
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome targeting signal 1 receptor PEX5protein30069% helix, 0% strandQ9U7C3
BT. brucei pgi PTS1 peptide ac-fnelshlprotein60% helix, 0% strandP13377

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 12 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12100.570.7935EDO
22320.530.7741empty
3510.400.8214EDO

Interfaces

1 interface between chains.

  • A–B · 581 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 3CV0 · Structure of Peroxisomal Targeting Signal 1 (PTS1) binding domain of Trypanosoma brucei… · the same entry in another collection · chain A against A, TM-score 1.00
  • P13377 · AlphaFold monomer V2.0 prediction for glucose-6-phosphate isomerase, glycosomal (P13377) · a predicted model of the same protein · chain B against A, TM-score 0.63

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.